gamma-aminobutyric acid has been researched along with 4,7,10,13,16,19-docosahexaenoic acid dopamine conjugate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezuglov, VV; Gan'shina, TS; Gretskaia, NM; Khaĭlov, NA; Kurdiumov, IN; Lebedeva, MA; Mirzoian, RS | 1 |
1 other study(ies) available for gamma-aminobutyric acid and 4,7,10,13,16,19-docosahexaenoic acid dopamine conjugate
Article | Year |
---|---|
[Peculiarities of cerebrovascular effects of GABA conjugate with docosahexaenoyl dopamine under conditions of separate and combined vascular pathology of brain and heart].
Topics: Animals; Bicuculline; Brain; Cerebrovascular Circulation; Coronary Circulation; Coronary Vessels; Dopamine; Drug Antagonism; GABA Agents; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Heart; Male; Rats | 2012 |